Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University, St Andrea Hospital, UOC Chirurgia 3, via di Grottarossa 1035-1039, 00189, Rome, Italy.
Division of Digestive Surgery and Liver Transplantation, Nice University Hospital Archet 2, 06200, Nice, France.
J Gastrointest Surg. 2017 Sep;21(9):1557-1561. doi: 10.1007/s11605-017-3449-3. Epub 2017 May 18.
Esophagocoloplasty represents a useful technique to restore the intestinal continuity after esophagogastrectomy. This technique has been used mainly after esophagogastric caustic injuries. The aim of this review is to assess the role of esophagogastrectomy with esophagocoloplasty for esophageal or gastric neoplasms.
A systematic literature search was performed using Embase, Medline, Cochrane, and PubMed databases to identify all studies published in the previous 25 years (1991-2016) reporting cases of esophagocoloplasty after esophagogastrectomy for malignancies. The systematic review was conducted according to the PRISMA guidelines.
The systematic review of the literature shows a morbidity rate of 57% and a mortality rate of 15% in the 93 reported cases of esophagocoloplasty performed for malignant diseases. However, R0 rate ranged from 76.1 to 85%, and 5-year survival was obtained in 11.9-32.8% of patients in the different series.
In highly selected cases of primary or relapsing gastric or esophageal neoplasms, esophagogastrectomy with esophagocoloplasty is a viable and useful option, which may guarantee complete tumor resection and long-term survival.
食管结肠重建术是一种在食管胃切除术后恢复肠道连续性的有效技术。该技术主要用于腐蚀性食管胃损伤。本综述旨在评估食管胃切除术后行食管结肠重建术治疗食管或胃肿瘤的作用。
使用 Embase、Medline、Cochrane 和 PubMed 数据库对过去 25 年（1991-2016 年）发表的所有报道恶性肿瘤行食管胃切除术后行食管结肠重建术病例的研究进行了系统性文献检索。根据 PRISMA 指南进行系统综述。
93 例恶性疾病行食管结肠重建术的病例中，发病率为 57%，死亡率为 15%。然而，不同系列的 R0 率为 76.1%至 85%，5 年生存率为 11.9%至 32.8%。
在原发性或复发性胃或食管肿瘤的高度选择病例中，食管胃切除术联合食管结肠重建术是一种可行且有用的选择，可保证肿瘤的完全切除和长期生存。
